365407
05/21/2025
Meadows of Kalida
755 Ottawa Street Kalida, OH 45853
F 0644
Level of Harm - Minimal harm or potential for actual harm
Residents Affected - Few
Coordinate assessments with the pre-admission screening and resident review program; and referring for services as needed.
Based on medical record review, review of the Pre-admission Screening and Resident Review (PASRR screening to determine if specialized services are needed) and staff interview, the facility failed ensure PASRR screenings were accurately completed. This affected one (#19) of three residents reviewed for PASRR screenings. The facility census was 58.
Findings include: Review of the medical record for Resident #19 revealed an admission date of 03/13/25. Diagnoses included unspecified psychosis not due to a substance or known physiological condition, unspecified dementia, unspecified hearing loss, and muscle weakness. Review of the Minimum Data Set (MDS) assessment, dated 03/31/25, revealed Resident #19 had a Brief Interview Mental Status (BIMS) score of 15, indicating intact cognition. The resident was dependent upon staff for activities of daily living (ADLs). Review of the PASRR, completed on 03/11/25, revealed Resident #19's diagnosis of unspecified psychosis not due to a substance or known physiological condition was not documented on the screening. Interview with Social Services Director (SSD) #272 verified Resident #19's PASRR did not accurately reflect the resident's mental health diagnosis and further confirmed a diagnosis of unspecified psychosis not due to a substance or know physiological condition should have been included on the PASRR screening.
Page 1 of 3
365407
365407
05/21/2025
Meadows of Kalida
755 Ottawa Street Kalida, OH 45853
F 0761
Level of Harm - Minimal harm or potential for actual harm
Residents Affected - Some
Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted professional principles; and all drugs and biologicals must be stored in locked compartments, separately locked, compartments for controlled drugs. **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 2. Observation on 05/21/25 at 12:49 P.M. of the 200-hall main medication room refrigerator, with the Director of Nursing (DON), revealed a plastic container which held eight vials of insulin. There were two vials of Novolog N 100 units per 10 milliliters (U/ml) with expiration dates of 12/31/24 and 01/31/25, a vial of Novolog R 100 U/10 ml with an expiration date of 03/31/25, two vials of Novolog 70/30 with an expiration date of 01/31/25 and one vial of Novolin R 100 U/10 ml with an expiration date of 03/31/25. Interview on 05/21/25 at 1:05 P.M. with the DON revealed the vials of insulin in the mail medication room refrigerator were used by all three halls of the facility for emergency situations, such as residents out of insulin or with new admissions. The DON verified the eight vials of insulin in the main medication room refrigerator were expired. Review of the facility policy titled, Medication Storage in the Facility, dated November 2018, revealed medications were stored safely, securely and properly, following manufactures recommendations or those of the supplier. Further review revealed outdated, contaminated, or deteriorated medications and those in containers that were cracked, soiled or without secure closures were immediately removed from inventory. All expired medications would be removed from the active supply and destroyed in the facility, regardless of the amount remaining.
Based on observation, staff interview, medical record review and review of the facility policy, the facility failed to ensure medications were not left unattended at a resident's bedside. This affected one (#111) of five residents reviewed for medication administration. In addition, the facility failed to ensure medications were removed from use and disposed of upon expiration. This had the potential to affect eight (#16, #22, #27, #30, #36, #39, #44 and #49) residents identified by the facility as receiving insulin. The facility census was 58.
Findings include: 1. Review of the medical record reveal Resident #111 was admitted on [DATE]. Diagnoses included cellulitis of the left lower limb, hypertensive heart and chronic kidney disease, acute on chronic diastolic heart failure, chronic kidney disease stage III, rheumatoid arthritis, type two diabetes mellitus with diabetic neuropathy, and major depressive disorder. Review of the Minimum Data Set (MDS) assessment, dated 03/13/25, revealed Resident #111 was cognitively intact and prescribed medications included anticoagulants, antibiotics, opioids, and anticonvulsants. Review of the Medication Administration Record (MAR) for May 2025 revealed on 05/18/25, during the morning medication administration, Resident #111 received the following medications: amiodarone (antiarrhythmic medication) 200 milligram (mg), bumetanide (diuretic) one mg, duloxetine (antidepressant) delayed release 60 mg, Eliquis (anticoagulant) five mg, folic acid (vitamin) one mg, gabapentin (antiseizure/nerve pain) 300 mg, glimepiride (diabetic medication) two mg, Jardiance (diabetic medication) 25 mg, levothyroxine (thyroid medication) 88 microgram (mcg), midodrine (antihypotensive) five mg, multivitamin tablet, oxybutynin chloride (urinary) tablet extended release 10 mg, pantoprazole (proton pump inhibitor) 40 mg, potassium chloride 20 milliequivalent (mEq), prednisone
365407
Page 2 of 3
365407
05/21/2025
Meadows of Kalida
755 Ottawa Street Kalida, OH 45853
F 0761
(corticosteroid) five mg, senna (supplement) 8.6 mg, and spironolactone (diuretic) 12.5 mg.
Level of Harm - Minimal harm or potential for actual harm
Observation on 05/18/25 at 9:54 A.M. revealed Resident #111 was sitting in her wheelchair, just outside of the resident's room door. Upon entering the resident's room, with the resident, a half full medication cup was observed on the bedside table.
Residents Affected - Some Interview on 05/18/25 at 10:00 A.M. with Licensed Practical Nurse (LPN) #283 verified leaving Resident #111's medications unattended at the bedside.
365407
Page 3 of 3